Specific code 2015 ICD-9-CM Diagnosis Code 289.81
Primary hypercoagulable state
  • 2015
  • Billable Thru Sept 30/2015
  • Non-Billable On/After Oct 1/2015

  • ICD-9-CM 289.81 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 289.81 should only be used for claims with a date of service on or before September 30, 2015. For claims with a date of service on or after October 1, 2015, use an equivalent ICD-10-CM code (or codes).
Convert to ICD-10-CM: 289.81 converts approximately to:
  • 2015/16 ICD-10-CM D68.51 Activated protein C resistance
    Or:
  • 2015/16 ICD-10-CM D68.52 Prothrombin gene mutation
    Or:
  • 2015/16 ICD-10-CM D68.59 Other primary thrombophilia
    Or:
  • 2015/16 ICD-10-CM D68.61 Antiphospholipid syndrome
    Or:
  • 2015/16 ICD-10-CM D68.62 Lupus anticoagulant syndrome
Approximate Synonyms
  • Activated Protein C resistance
  • Anticardiolipin syndrome
  • Antiphospholipid syndrome
  • Antiphospholipid syndrome complication in pregnancy
  • Antiphospholipid syndrome in pregnancy
  • Antiphospholipid syndrome postpartum
  • Antithrombin 3 deficiency
  • Antithrombin III deficiency
  • Factor 5 Leiden mutation
  • Factor 5 Leiden mutation, heterozygous
  • Factor 5 Leiden mutation, homozygous
  • Factor V Leiden mutation
  • Factor V Leiden mutation, heterozygous
  • Factor V Leiden mutation, homozygous
  • Hereditary antithrombin III deficiency
  • Hereditary heparin cofactor II deficiency
  • Hereditary protein C deficiency
  • Hereditary protein S deficiency
  • Hereditary thrombophilia
  • Heterozygous Factor V Leiden mutation
  • Heterozygous protein C deficiency
  • Heterozygous protein S deficiency
  • Heterozygous prothrombin G20210A mutation
  • Homozygous Factor V Leiden mutation
  • Homozygous protein C deficiency
  • Homozygous protein S deficiency
  • Homozygous prothrombin G20210A mutation
  • Hypercoagulability state
  • Hypercoagulable state
  • Hypercoagulable state (tendency to form clots)
  • Hypercoagulable state, primary
  • Lupus anticoagulant
  • Lupus anticoagulant disorder
  • Postpartum (after childbirth) antiphospholipid syndrome
  • Postpartum antiphospholipid syndrome
  • Protein C deficiency disease
  • Protein C deficiency disorder
  • Protein C resistance
  • Protein S deficiency disease
  • Protein S deficiency disorder
  • Prothrombin G20210A mutation
  • Prothrombin gene mutation
  • Resistance to activated protein C due to Factor V Leiden
  • Thrombophilia due to acquired antithrombin III deficiency
  • Thrombophilia due to acquired protein C deficiency
  • Thrombophilia due to acquired protein S deficiency
  • Thrombophilia due to antiphospholipid antibody
  • Upper gastrointestinal hemorrhage associated with hypercoagulability state
289.81 Excludes
  • anti-phospholipid antibody, finding without diagnosis (795.79)
  • anti-phospholipid antibody with hemorrhagic disorder (286.53)
  • lupus anticoagulant (LAC) finding without diagnosis (795.79)
  • lupus anticoagulant (LAC) with hemorrhagic disorder (286.53)
  • secondary activated protein C resistance (289.82)
  • secondary antiphospholipid antibody syndrome (289.82)
  • secondary lupus anticoagulant with hypercoagulable state (289.82)
  • secondary systemic lupus erythematosus [SLE] inhibitor with hypercoagulable state (289.82)
  • systemic lupus erythematosus [SLE] inhibitor finding without diagnosis (795.79)
  • systemic lupus erythematosus [SLE] inhibitor with hypercoagulable state (286.53)
Applies To
  • Activated protein C resistance
  • Antiphospholipid antibody syndrome
  • Antithrombin III deficiency
  • Factor V Leiden mutation
  • Lupus anticoagulant with hypercoagulable state
  • Protein C deficiency
  • Protein S deficiency
  • Prothrombin gene mutation
  • Systemic lupus erythematosus [SLE] inhibitor with hypercoagulable state
ICD-9-CM Volume 2 Index entries containing back-references to 289.81:
  • Antibody
    • anticardiolipin 795.79
      • with
        • hemorrhagic disorder 286.53
        • hypercoagulable state 289.81
    • antiphosphatidylglycerol 795.79
      • with
        • hemorrhagic disorder 286.53
        • hypercoagulable state 289.81
    • antiphosphatidylinositol 795.79
      • with
        • hemorrhagic disorder 286.53
        • hypercoagulable state 289.81
    • antiphosphatidylserine 795.79
      • with
        • hemorrhagic disorder 286.53
        • hypercoagulable state 289.81
    • antiphospholipid 795.79
      • with
        • hemorrhagic disorder 286.53
        • hypercoagulable state 289.81
  • Anticoagulant
    • lupus (LAC) 795.79
      • with
        • hemorrhagic disorder 286.53
        • hypercoagulable state 289.81
  • Deficiency, deficient
    • antithrombin III 289.81
    • protein 260
      • anemia 281.4
      • C 289.81
      • plasma - see Deficiency, plasma, protein
      • S 289.81
  • Factor
    • V Leiden mutation 289.81
  • Hypercoagulation syndrome (primary) 289.81
  • Inhibitor
    • systemic lupus erythematosus (presence of) 795.79
      • with
        • hemorrhagic disorder 286.53
        • hypercoagulable state 289.81
  • Lupus 710.0
    • anticoagulant 795.79
      • with
        • hemorrhagic disorder 286.53
        • hypercoagulable state 289.81
  • Mutation(s)
    • factor V Leiden 289.81
    • prothrombin gene 289.81
  • Resistance, resistant (to)
    • activated protein C 289.81
  • State
    • hypercoagulable (primary) 289.81
  • Syndrome - see also Disease
    • anticardiolipin antibody 289.81
    • antiphospholipid antibody 289.81
ICD-9-CM codes are used in medical billing and coding to describe diseases, injuries, symptoms and conditions. ICD-9-CM 289.81 is one of thousands of ICD-9-CM codes used in healthcare. Although ICD-9-CM and CPT codes are largely numeric, they differ in that CPT codes describe medical procedures and services. Can't find a code? Start at the root of ICD-9-CM, check the 2015 ICD-9-CM Index or use the search engine at the top of this page to lookup any code.